Search academic texts

Information × Registration Number 0299U004085, 0197U013674 , R & D reports Title To evahuate the informativity and to developecriterious system of tumo-marker bombesin using for the diagnostics, the prognosis and the evahuation of antitumor therapy efficiensy lung cancer. popup.stage_title Head Mitryayeva N.A., Registration Date 01-06-2000 Organization Grigor'ev Institut for Medical Radiology popup.description2 Object of recearch. Blood plasma bombesin of 111 patients with lung cancer and 43 patients with chronic nonspecitic lung diseases. Objecttive. To improve the diagnostics and the prognosis, to increase the efficiensy of lung cancer treatment by evaluation informativity and development of the criterious system for tumor marker bombesin using. Methods and Equipment. Clinical, radioimmunological, mathematical. Results. Have been shown 98% specificity and 80% sensitivity of bombesin as the marker of lung small-cell cancer in comparison with other tumor markers for lung cancer diagnostics and monitoring of antitumor efficiensy. Novelty. Have been worked out that the criterious of bombesin may be used as the marker of lung small-cell cancer for differential diagnostics of lung cancer and evaluation of antitumor therapy efficiensy. Efficiensy. Had been improved diagnostics and efficasy of antitumor therapy. Sphere of application. Medcine, Research Institutes of Oncology, Regional Oncological Dispensarys. Product Description popup.authors popup.nrat_date 2020-04-03 Close